Therefore, lncRNA PCAT18 is also an important target for evaluating the occurrence and therapeutic effect of adenocarcinoma, such as gastric adenocarcinoma and prostate cancer; however, its role and function in TNBC has not yet been reported. This evidence concerns the gene PCAT18 and prostate carcinoma.